91桃色

Neurotransmitters; Neurons; Gamma-aminobutyric acid; Central nervous system; Neuromodulators

Introduction

Neurotransmitters are often referred to as chemical messengers. Communication between neurons occurs within the synaptic cleft, where electrical signals are converted into chemical ones through the release of neurotransmitters. Neurotransmitters are essential for communication between neurons in the central nervous system (CNS), which includes the brain and spinal cord [1]. There are several neurotransmitters in the CNS that play crucial roles in regulating various physiological and behavioral functions, such as learning, memory, emotion, movement, and sensory processing. Among the most important neurotransmitters are gamma-aminobutyric acid (GABA), which is the primary inhibitory neurotransmitter in the brain, and glutamate, which is the primary excitatory neurotransmitter. Other neurotransmitters in the CNS include dopamine, serotonin, acetylcholine, norepinephrine, and histamine. Understanding the role of neurotransmitters in the CNS is crucial for developing effective treatments for these disorders [2,3].

Neurotransmission is the process by which neurons communicate with each other and with other cells in the body. It is a critical process that enables the transmission of information throughout the nervous system, including the brain and spinal cord. During neurotransmission, neurotransmitters are released from the presynaptic neuron and bind to specific receptors on the postsynaptic neuron or target cell. This binding can either excite or inhibit the activity of the postsynaptic neuron, allowing for the propagation of electrical and chemical signals throughout the nervous system. The proper functioning of neurotransmission is crucial for a wide range of physiological processes, including sensory perception, motor control, cognition, and emotional regulation. Dysregulation of neurotransmission has been implicated in a variety of neurological and psychiatric disorders, such as Parkinson’s disease, depression, and schizophrenia. Some of the major neurotransmitters in the CNS include glutamate, which is the primary excitatory neurotransmitter, and gamma-aminobutyric acid (GABA), which is the primary inhibitory neurotransmitter. Other important neurotransmitters in the CNS include dopamine, serotonin, acetylcholine, and norepinephrine, among others [4-7]. These neurotransmitters play crucial roles in a wide range of brain functions, such as cognition, emotion, movement, and sensation. Dysfunction or imbalances in these neurotransmitters have been associated with various neurological and psychiatric disorders, such as depression, anxiety, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. Some single ions are also considered neurotransmitters. This causes a specific reaction in the receiving neuron. Neuromodulators are different from neurotransmitters as they can affect large numbers of neurons and are not limited to the synaptic cleft. They regulate populations of neurons over a slower time course than excitatory and inhibitory transmitters. Excitotoxicity has been linked to several chronic diseases, including ischemic stroke, epilepsy, Alzheimer’s disease, Huntington disease, amyotrophic lateral sclerosis, and Parkinson’s disease. The main neurotransmitter found in the body is a small molecule known as acetylcholine. It has a significant role in the peripheral nervous system, where it is released by motor neurons and autonomic nervous system neurons. In the central nervous system, the primary excitatory transmitter is glutamate. Fluoxetine is a medication that belongs to the selective serotonin re-uptake inhibitor (SSRI) class, which prevents the re-uptake of serotonin by the presynaptic cell, increasing the amount of serotonin available at the synapse and potentially enhancing the effect of naturally released serotonin [8].

Neuromodulators are a class of signaling molecules that are released by neurons and can modify the activity of other neurons. They do not act as classical neurotransmitters by directly causing depolarization or hyperpolarization of postsynaptic cells, but instead modulate the effects of neurotransmitters on the target cells. Neuromodulators can act over longer time periods and can affect the behavior and function of large groups of neurons. Examples of neuromodulators include dopamine, serotonin, and acetylcholine. They play important roles in a variety of physiological and behavioral processes such as mood regulation, memory, and attention. Dysregulation of neuromodulator systems has been implicated in a number of neurological and psychiatric disorders. Many neuromodulators, including dopamine, are classified as monoamines. Noradrenaline, another monoamine, is the primary neurotransmitter in the sympathetic nervous system, where it regulates the activity of various organs in the body, such as controlling blood pressure, heart rate, liver function, and other functions. Serotonin is involved in various functions such as sleep, memory, appetite, mood, and others, as neurons that use serotonin project to different parts of the nervous system. Finally, histamine, the last of the major monoamines, plays a role in metabolism, temperature regulation, hormone regulation, and the sleep-wake cycle, among other functions.

Communication between brain cells and other cells in the body occurs through small molecules called neurotransmitters (NT). These molecules are released by neurons and are picked up by target cells through NT receptors. The genes that control NT and NT receptor function may play a role in human behavior [9,10]. Changes in these genes can impact behavior and researchers are studying these changes. In neurons, drugs called agonists can activate NT receptors either directly or indirectly. Once the NT has completed its function, it is stopped by three mechanisms. NT receptors are located on postsynaptic neurons, while NT autoreceptors are located on presynaptic neurons. The gap between neurons is called a neural synapse, and NTs must cross this space to communicate with other cells. This process is called neurotransmission. Problems can occur in this process, such as when neurons do not produce enough NT, or when there is too much NT released. Excessive NT release has been linked to neurological diseases such as epilepsy, multiple sclerosis, Alzheimer’s disease, stroke, and ALS.

Role of neurotransmitters

Neurotransmitters play a crucial role in the proper functioning of the nervous system by facilitating communication between neurons [11-14]. They transmit signals across synapses, which are the junctions between two neurons or between a neuron and a target cell, such as a muscle or gland. Neurotransmitters are responsible for a wide range of functions, including regulating mood, emotion, cognition, sensation, movement, and autonomic nervous system activity, such as heart rate and breathing. Some neurotransmitters, such as dopamine and serotonin, are involved in the regulation of reward and pleasure, while others, such as GABA and glycine, have inhibitory effects on the nervous system, helping to prevent overstimulation [15]. Dysregulation of neurotransmitters has been implicated in various neurological and psychiatric disorders, including depression, anxiety, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. Drugs that target specific neurotransmitters, such as antidepressants and antipsychotics, are commonly used to treat these disorders.

Major inhibitory neurotransmitter

The major inhibitory neurotransmitter in the central nervous system (CNS) is gamma-aminobutyric acid (GABA). GABA works by binding to GABA receptors on the postsynaptic neuron, which causes an influx of negatively charged chloride ions into the neuron, hyperpolarizing the membrane potential and making it less likely to fire an action potential. This inhibitory effect on neuronal activity helps to regulate the excitatory activity in the brain and maintain a balance between excitation and inhibition [16,17].

Discussion

The neurotransmission effect on human behavior is complex and multifaceted, as it involves many different neurotransmitters and brain regions. However, the inhibitory effect of GABA on neuronal activity is generally associated with calming and relaxing effects on behavior. For example, drugs that enhance GABA activity, such as benzodiazepines, are commonly used as anxiolytics and sedatives. On the other hand, a decrease in GABA activity has been linked to anxiety disorders, seizure disorders, and insomnia, among other conditions. Overall, the proper balance of GABAergic inhibition and glutamatergic excitation is essential for normal brain function and behavior.

Conclusion

In conclusion, neurotransmitters play a critical role in the functioning of the central nervous system. The proper functioning and balance of neurotransmitters is essential for healthy brain activity and mental health. The intricate interplay between various neurotransmitters is vital for transmitting, processing, and modulating information throughout the body. Imbalances or deficiencies in neurotransmitters can lead to a variety of neurological and mental health disorders, such as Parkinson’s disease, depression, anxiety, and schizophrenia. The study of neurotransmitters in the CNS is an ongoing area of research, with the potential for new insights and treatments for neurological and mental health disorders.

Acknowledgement

Not applicable.

Conflict of Interest

Author declares no conflict of interest.

1. Kodirov SA, Takizawa S, Joseph J, Kandel ER, Shumyatsky GP, et al. (2006) Proc Natl Acad Sci USA 103:15218-1523.

, ,

2. Yang JL, Sykora P, Wilson DM, Mattson MP, Bohr VA (2011) Mech Ageing Dev132:405-411.

, ,

3. Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, et al. (2008) Cell 135:825-837.

, ,

4. Miller GM (2011) J Neurochem 116:164-176.

, ,

5. Bittigau P, Ikonomidou C (1997) J Child Neurol 12:471-485.

, ,

6. Heemskerk AD, Bang ND, Mai NTH, Chau TTH, Phu NH, et al. (2016) N Engl J Med 374: 124-134.

, , Crossref

7. Sharma SR, Lynrah KG, Sharma N, Lyngdoh M (2013) Ann Indian Acad Neurol 16: 82-84.

, , Crossref

8. Feleke BE, Feleke TE, Biadglegne F (2019) BMC Pulm Med 19: 1-9.

, , Crossref

9. World Health Organization (2013) Geneva.

                

10. Soria J, Metcalf T, Mori N, Newby RE, Montano SM, et al. (2019) BMC Infect Dis 19: 1-7.

, , Crossref

11. Torok ME (2015) Br Med Bull 113: 117-131.

, , Crossref

12. Lim JU, Lee JH, Kim JS, Hwang YI, Kim TH, et al. (2017) Int J COPD 12: 2465-2475.

, , Crossref

13. Iype T, Pillai AK, Cherian A, Nujum ZT, Pushpa C, et al. (2014) Ann Indian Acad Neurol 17: 281-286.

, , Crossref

14. Marais S, Pepper DJ, Schutz C, Wilkinson RJ, Meintjes G (2011) PLoS One 6.

, , Crossref

15. Rocha NP, Fortes RC (2015) Arq Bras Cir Dig 28: 193-196.

, , Crossref

16. Van Laarhoven A, Dian S, Ruesen C, Hayati E, Damen MSMA, et al. (2017) J Infect Dis 215: 1029-1039.

, , Crossref

17. Gunarsa RG, Simadibrata M, Syam AF, Timan IS, Setiati S, et al. (2015) Indones J Gastro Hepatol Dig Endosc 12: 89-94.

, Crossref